193 related articles for article (PubMed ID: 20818671)
1. Grasping premanifest Huntington's disease - shaping new endpoints for new trials.
Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
Mov Disord; 2010 Dec; 25(16):2858-62. PubMed ID: 20818671
[TBL] [Abstract][Full Text] [Related]
2. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
[TBL] [Abstract][Full Text] [Related]
3. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures.
Reilmann R; Bohlen S; Kirsten F; Ringelstein EB; Lange HW
Mov Disord; 2011 Oct; 26(12):2267-73. PubMed ID: 21661053
[TBL] [Abstract][Full Text] [Related]
4. Impaired postural stability as a marker of premanifest Huntington's disease.
Salomonczyk D; Panzera R; Pirogovosky E; Goldstein J; Corey-Bloom J; Simmons R; Gilbert PE
Mov Disord; 2010 Oct; 25(14):2428-33. PubMed ID: 20818666
[TBL] [Abstract][Full Text] [Related]
5. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
6. Unified Huntington's disease rating scale: a follow up.
Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
[TBL] [Abstract][Full Text] [Related]
7. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
8. Objective assessment of progression in Huntington's disease: a 3-year follow-up study.
Reilmann R; Kirsten F; Quinn L; Henningsen H; Marder K; Gordon AM
Neurology; 2001 Sep; 57(5):920-4. PubMed ID: 11552034
[TBL] [Abstract][Full Text] [Related]
9. Complex movement behaviour and progression of Huntington's disease.
Andrich J; Saft C; Ostholt N; Müller T
Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
[TBL] [Abstract][Full Text] [Related]
10. Coordination of prehensile forces during precision grip in Huntington's disease.
Gordon AM; Quinn L; Reilmann R; Marder K
Exp Neurol; 2000 May; 163(1):136-48. PubMed ID: 10785452
[TBL] [Abstract][Full Text] [Related]
11. Huntington's disease: objective assessment of posture--a link between motor and functional deficits.
Reilmann R; Rumpf S; Beckmann H; Koch R; Ringelstein EB; Lange HW
Mov Disord; 2012 Apr; 27(4):555-9. PubMed ID: 22241673
[TBL] [Abstract][Full Text] [Related]
12. Unified Huntington's disease rating scale: clinical practice and a critical approach.
Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
[TBL] [Abstract][Full Text] [Related]
13. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
[TBL] [Abstract][Full Text] [Related]
14. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological deterioration over time in patients with Huntington's disease.
Lefaucheur JP; Ménard-Lefaucheur I; Maison P; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
Mov Disord; 2006 Sep; 21(9):1350-4. PubMed ID: 16721731
[TBL] [Abstract][Full Text] [Related]
16. Bradykinesia in Huntington's disease. A prospective, follow-up study.
García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
[TBL] [Abstract][Full Text] [Related]
17. Impaired Isometric Force Matching in Upper and Lower Limbs Revealed by Quantitative Motor Assessments in Huntington's Disease.
Medzech S; Sass C; Bohlen S; Lange HW; Koch R; Schubert R; Ringelstein EB; Reilmann R
J Huntingtons Dis; 2019; 8(4):483-492. PubMed ID: 31450507
[TBL] [Abstract][Full Text] [Related]
18. The relationship between CAG repeat length and clinical progression in Huntington's disease.
Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
[TBL] [Abstract][Full Text] [Related]
19. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
Wolf RC; Vasic N; Schönfeldt-Lecuona C; Landwehrmeyer GB; Ecker D
Brain; 2007 Nov; 130(Pt 11):2845-57. PubMed ID: 17855375
[TBL] [Abstract][Full Text] [Related]
20. Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness.
Rao AK; Muratori L; Louis ED; Moskowitz CB; Marder KS
Gait Posture; 2009 Apr; 29(3):433-6. PubMed ID: 19111470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
